Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Reported: November 27, 2024 Initiated: November 11, 2024 #D-0060-2025
Product Description
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Reason for Recall
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Details
- Recalling Firm
- Safecor Health, LLC
- Units Affected
- 587 boxes
- Distribution
- USA nationwide.
- Location
- Woburn, MA
Frequently Asked Questions
What product was recalled? ▼
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01. Recalled by Safecor Health, LLC. Units affected: 587 boxes.
Why was this product recalled? ▼
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on November 27, 2024. Severity: Moderate. Recall number: D-0060-2025.
Related Recalls
NHTSA Critical
LEXUS 2025: POWER TRAIN:AUTOMATIC TRANSMISSION
LEXUS · 2026-02-18
NHTSA Critical
CADILLAC,CHEVROLET,GMC 2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CADILLAC,CHEVROLET,GMC · 2026-02-13
NHTSA Critical
CHEVROLET,GMC 2020-2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CHEVROLET,GMC · 2026-02-12
NHTSA Critical
CADILLAC 2024: BACK OVER PREVENTION:SOFTWARE
CADILLAC · 2026-02-12
NHTSA Critical
NISSAN 2024-2025: FUEL SYSTEM, GASOLINE:FUEL INJECTION SYSTEM:THROTTLEBODY/MANIFOLD
NISSAN · 2026-02-12